| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.53 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |